Disease Info Card

Pycnodysostosis

Information about Pycnodysostosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Pycnodysostosis

Most recent studies have shown that Pycnodysostosis shares some biological mechanisms with acro-osteolysis, albers-schonberg-disease, bone-diseases, bone-diseases-developmental, cleidocranial-dysplasia, congenital-abnormality, craniofacial-dysostosis, cytogenetic-abnormality, dwarfism, dysostoses, dysplasia, fracture, hereditary-diseases, osteochondrodysplasias, osteomyelitis, osteoporosis, osteosclerosis, potassium-deficiency, sclerosis, skeletal-dysplasia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Pycnodysostosis, and have been seen in publications frequently: Bone Remodeling, Bone Resorption, Cell Division, Chondrocyte Differentiation, Endochondral Ossification, Growth Hormone Secretion, Interleukin-1 Secretion, Intramembranous Ossification, Localization, Meiosis Ii, Ossification, Osteoclast Differentiation, Pathogenesis, Phagocytosis, Secretion, Senescence, Tissue Development, Tissue Remodeling, Tooth Eruption, Translation

Quite a number of genes have been found to play important roles in Pycnodysostosis, such as BGLAP, CALCA, CDKN2D, CTSK, ECM1, GGH, GH1, IGF1, IL6, IL6R, MTSS1, PTH, TNFRSF11A, TNFRSF11B. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.